COVID-19 in two severe asthmatics receiving benralizumab: busting the eosinophilia myth
Andreas Renner, Katharina Marth, Karin Patocka, Marco Idzko, Wolfgang Pohl
Abstract
<b>Experience with very mild #COVID19 disease courses in two severe eosinophilic asthmatics with complete eosinophil depletion due to benralizumab treatment counters the recent theories that eosinophilia is protective in COVID-19 infections</b>https://bit.ly/3cnEFvg
Topics & Concepts
BenralizumabMedicineEosinophiliaCoronavirus disease 2019 (COVID-19)EosinophilSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakImmunologyDiseaseAsthmaVirologyInternal medicineInfectious disease (medical specialty)MepolizumabOutbreakAsthma and respiratory diseasesChronic Obstructive Pulmonary Disease (COPD) ResearchClimate Change and Health Impacts